Quick Takeaways
- Barbara Ryan has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $490,178.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Barbara Ryan
- Location
- Norwalk, CT
- Summary
- The estimated net worth of Barbara Ryan is at least $490,178 dollars as of 13 Mar 2026. Barbara Ryan is the Director of MiNK Therapeutics, Inc. and owns shares of MiNK Therapeutics, Inc. (INKT) stock worth about $312.2K. Barbara Ryan is the Director of Indivior Pharmaceuticals, Inc. and owns shares of Indivior Pharmaceuticals, Inc. (INDV) stock worth about $177.9K. Barbara Ryan is the Director of INVO Fertility, Inc. and owns shares of INVO Fertility, Inc. (IVF) stock worth about $37.
- Signature
- /s/Alice Givens, Power of Attorney
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Barbara Ryan and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: MiNK Therapeutics, Inc. ($312,211).
- Past-year value change for that position: -$27,478.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Barbara Ryan
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| INKT | MiNK Therapeutics, Inc. | Director | $312,211 | -$27,478 | -8.1% | 09 Mar 2026 |
| INDV | Indivior Pharmaceuticals, Inc. | Director | $177,930 | +$28,687 | +19% | 13 Mar 2026 |
| IVF | INVO Fertility, Inc. | Director | $37 | 26 Aug 2025 | ||
| AZTR | Azitra, Inc. | Director | 19 Dec 2025 |
Insider Transactions Reported by Barbara Ryan:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.